The AKI care bundle: all bundle components are created equal—are they?

the PrevAKI Investigators

doi:10.1007/s00134-021-06601-0

The AKI care bundle: all bundle components are created equal—are they?

the PrevAKI Investigators

Research output: Contribution to journal › Letter › peer-review

23 Citations (Scopus)

Original language	English
Number of pages	4
Journal	Intensive Care Medicine
Volume	48
Issue number	2
Early online date	18 Dec 2021
DOIs	https://doi.org/10.1007/s00134-021-06601-0
Publication status	E-pub ahead of print - 18 Dec 2021

Access to Document

10.1007/s00134-021-06601-0

Cite this

@article{a936c7431d5e4bb6941ffd75b4c1a24c,

title = "The AKI care bundle: all bundle components are created equal—are they?",

author = "{the PrevAKI Investigators} and {von Groote}, {Thilo C.} and Marlies Ostermann and Forni, {Lui G.} and Melanie Meersch-Dini and Alexander Zarbock and Christoph Schmidt and Andreas Hoffmeier and Hugo Aken and Carola Wempe and Mira K{\"u}llmar and Gianluca Lucchese and Kamran Baig and Armando Cennamo and Ronak Rajani and Stuart McCorkell and Christian Arndt and Hinnerk Wulf and Marc Irqsusi and Fabrizio Monaco and Prima, {Ambra Licia Di} and Alvarez, {Mercedes Garc{\'i}a} and Stefano Italiano and Bagan, {Jordi Miralles} and Gudrun Kunst and Shrijit Nair and Camilla L{\textquoteright}Acqua and Eric Hoste and Wim Vandenberghe and Honore, {Patrick M.} and Kellum, {John A.} and Philippe Grieshaber and Christina Massoth and Raphael Weis",

note = "Funding Information: Open Access funding enabled and organized by Projekt DEAL. The trials were supported by the German Research Foundation (KFO342-1, ZA428/18-1 and ZA428/21-1) to Professor Alexander Zarbock. Funding Information: TCVG and MO declared no conflict of interest. AZ reported receiving research grants from Baxter, Fresenius, Astute Medical, and Astellas and receiving personal fees from Fresenius, AM Pharma and Biomerieux. MM reported receiving personal fees from Astute Medical, FMC, and Baxter. LGF declared research support and personal fees from Astute Medical, La Jolla Pharmaceuticals, Medibeacon, Baxter, and Fresenius. ",

year = "2021",

month = dec,

day = "18",

doi = "10.1007/s00134-021-06601-0",

language = "English",

volume = "48",

journal = "Intensive Care Medicine",

issn = "0342-4642",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - The AKI care bundle

T2 - all bundle components are created equal—are they?

AU - the PrevAKI Investigators

AU - von Groote, Thilo C.

AU - Ostermann, Marlies

AU - Forni, Lui G.

AU - Meersch-Dini, Melanie

AU - Zarbock, Alexander

AU - Schmidt, Christoph

AU - Hoffmeier, Andreas

AU - Aken, Hugo

AU - Wempe, Carola

AU - Küllmar, Mira

AU - Lucchese, Gianluca

AU - Baig, Kamran

AU - Cennamo, Armando

AU - Rajani, Ronak

AU - McCorkell, Stuart

AU - Arndt, Christian

AU - Wulf, Hinnerk

AU - Irqsusi, Marc

AU - Monaco, Fabrizio

AU - Prima, Ambra Licia Di

AU - Alvarez, Mercedes García

AU - Italiano, Stefano

AU - Bagan, Jordi Miralles

AU - Kunst, Gudrun

AU - Nair, Shrijit

AU - L’Acqua, Camilla

AU - Hoste, Eric

AU - Vandenberghe, Wim

AU - Honore, Patrick M.

AU - Kellum, John A.

AU - Grieshaber, Philippe

AU - Massoth, Christina

AU - Weis, Raphael

N1 - Funding Information: Open Access funding enabled and organized by Projekt DEAL. The trials were supported by the German Research Foundation (KFO342-1, ZA428/18-1 and ZA428/21-1) to Professor Alexander Zarbock. Funding Information: TCVG and MO declared no conflict of interest. AZ reported receiving research grants from Baxter, Fresenius, Astute Medical, and Astellas and receiving personal fees from Fresenius, AM Pharma and Biomerieux. MM reported receiving personal fees from Astute Medical, FMC, and Baxter. LGF declared research support and personal fees from Astute Medical, La Jolla Pharmaceuticals, Medibeacon, Baxter, and Fresenius.

PY - 2021/12/18

Y1 - 2021/12/18

UR - http://www.scopus.com/inward/record.url?scp=85121456900&partnerID=8YFLogxK

U2 - 10.1007/s00134-021-06601-0

DO - 10.1007/s00134-021-06601-0

M3 - Letter

AN - SCOPUS:85121456900

SN - 0342-4642

VL - 48

JO - Intensive Care Medicine

JF - Intensive Care Medicine

IS - 2

ER -

The AKI care bundle: all bundle components are created equal—are they?

Access to Document

Other files and links

Cite this